about
CervoMed Inc is a clinical stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the revers...
Read More
7.60
0.01
(0.13%)
5,784
XNAS Volume
XNAS 13 Jan, 2026 10:48 AM (EST)
Not Eligible
Expensive Valuation
Technically Neutral
CervoMed Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..